Trial Profile
Nabilone for non-motor symptoms in Parkinson's disease: An open-label study to evaluate long-term safety and efficacy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Mar 2020
Price :
$35
*
At a glance
- Drugs Nabilone (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- 05 Mar 2020 Status changed from recruiting to completed.
- 20 Apr 2018 New trial record